Colorectal Cancer Clinical Trials in Las Vegas, NV

Colorectal Cancer Clinical Trials in Las Vegas, NV

View the best 10 colorectal cancer medical studies in Las Vegas, Nevada. Access promising new therapies by applying to a Las Vegas-based Colorectal Cancer clinical trial.

Trials in Las Vegas, Nevada

Here are the top 10 medical studies for colorectal cancer in Las Vegas, Nevada

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: February 11th, 2025

Image of Mayo Clinic of Scottsdale in Scottsdale, United States.

LOXO-292

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug called selpercatinib in patients with advanced cancers that have specific gene changes. The drug aims to block a gene that helps cancer grow, potentially slowing or stopping the disease.
Image of HonorHealth Research Institute - Bisgrove in Scottsdale, United States.

Autogene Cevumeran +1 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial tests a personalized cancer vaccine and an immune-boosting drug in cancer patients. The vaccine teaches the body to attack cancer, while the drug helps immune cells find and kill hidden cancer cells. This approach aims to induce strong anti-tumor responses by selecting suitable vaccines based on the patient's existing immune system.
Image of Univ of Colorado Cancer Center /ID# 231574 in Aurora, United States.

ABBV-400

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial tests a new drug called ABBV-400 for adults with advanced cancers. The study aims to find the best dose and see how well it works, both alone and with other treatments. Patients will receive the drug through an IV and be closely monitored for effects and side effects.
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of Exelixis Site #1 in Tucson, United States.

XL092

Recruiting1 awardPhase 1
This trial is testing a new drug called XL092 alone and with other cancer drugs in patients with advanced solid tumors. The goal is to see if these treatments can safely stop or slow tumor growth and help the immune system fight cancer more effectively.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Trastuzumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Ulixertinib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of Northeast Alabama Regional Medical Center in Anniston, United States.

Oxaliplatin +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is testing a combination of drugs to treat patients who have had surgery for stage II colon cancer, to see if it is more effective than a standard combination of drugs.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Eflornithine +1 More

Enzyme Inhibitor

Recruiting1 awardPhase 3
This trial will test a combination of drugs to see if they are effective in reducing the chance of cancer recurrence or developing new cancers.
Image of NRG Oncology - Pittsburgh Center in Pittsburgh, United States.

mFOLFIRINOX

Recruiting1 awardPhase 2 & 3
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.

Popular Filters

Age 65+
Phase 3
< 50 mile distance
No Placebo

Phase 3 Trials

Jonesboro, Arkansas

Chemotherapy

Chemotherapy + Bevacizumab + Atezolizumab for Colorectal Cancer

Recruiting2 awardsPhase 3
Fontana, California
This trial is testing a combination of chemotherapy drugs, bevacizumab, and atezolizumab to treat patients with metastatic colorectal cancer.
Anchorage, Alaska

Chemotherapy

Chemotherapy + Atezolizumab for Colon Cancer

Recruiting2 awardsPhase 3
Fontana, California
This trial is testing whether adding atezolizumab to standard chemotherapy works better than chemotherapy alone for patients with stage III colon cancer who have a specific genetic defect. The chemotherapy drugs aim to kill cancer cells, while atezolizumab helps the immune system attack the cancer. Researchers hope this combination will improve survival rates and quality of life for these patients.
Birmingham, Alabama

Enzyme Inhibitor

Eflornithine + Sulindac for Colorectal Cancer Prevention

Recruiting1 awardPhase 3
Rancho Mirage, California
This trial will test a combination of drugs to see if they are effective in reducing the chance of cancer recurrence or developing new cancers.
Anniston, Alabama

Alkylating agents

Chemotherapy +/− Bevacizumab for Stage II Colon Cancer

Recruiting2 awardsPhase 3
Palm Springs, California
This trial is testing a combination of drugs to treat patients who have had surgery for stage II colon cancer, to see if it is more effective than a standard combination of drugs.
Pittsburgh, Pennsylvania

Chemotherapy Tailored by ctDNA Status for Colon Cancer

Recruiting1 awardPhase 2 & 3
Loma Linda, California
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Birmingham, Alabama

Small Molecule

MRTX849 + Cetuximab for Colorectal Cancer

Recruiting2 awardsPhase 3
Las Vegas, Nevada
This trial is testing a new treatment for patients with colorectal cancer. The treatment combines two drugs that work together to block cancer growth and prevent its spread. One of the drugs has shown promise in treating other types of cancer as well.

Trials With No Placebo

San Francisco, California

GSK-3β inhibitor

9-ING-41 for Advanced Cancers

Recruiting1 awardPhase 2
Las Vegas, Nevada
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Anchorage, Alaska

Monoclonal Antibodies

Trastuzumab + Pertuzumab vs. Cetuximab + Irinotecan for Colorectal Cancer

Recruiting1 awardPhase 2
Kingman, Arizona
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.
Scottsdale, Arizona

Cancer Vaccine

Autogene Cevumeran + Atezolizumab for Cancer

Recruiting1 awardPhase 1
Las Vegas, Nevada
This trial tests a personalized cancer vaccine and an immune-boosting drug in cancer patients. The vaccine teaches the body to attack cancer, while the drug helps immune cells find and kill hidden cancer cells. This approach aims to induce strong anti-tumor responses by selecting suitable vaccines based on the patient's existing immune system.
Scottsdale, Arizona

Tyrosine Kinase Inhibitor

Selpercatinib for Solid Tumors

Recruiting1 awardPhase 1 & 2
Las Vegas, Nevada
This trial is testing a new oral drug called selpercatinib in patients with advanced cancers that have specific gene changes. The drug aims to block a gene that helps cancer grow, potentially slowing or stopping the disease.
Jonesboro, Arkansas

Chemotherapy

Chemotherapy + Bevacizumab + Atezolizumab for Colorectal Cancer

Recruiting2 awardsPhase 3
Fontana, California
This trial is testing a combination of chemotherapy drugs, bevacizumab, and atezolizumab to treat patients with metastatic colorectal cancer.
Anchorage, Alaska

Chemotherapy

Chemotherapy + Atezolizumab for Colon Cancer

Recruiting2 awardsPhase 3
Fontana, California
This trial is testing whether adding atezolizumab to standard chemotherapy works better than chemotherapy alone for patients with stage III colon cancer who have a specific genetic defect. The chemotherapy drugs aim to kill cancer cells, while atezolizumab helps the immune system attack the cancer. Researchers hope this combination will improve survival rates and quality of life for these patients.

View More Related Trials

da Vinci SP Surgical System

Duloxetine

Irinotecan +4 More

Capecitabine +4 More

Amivantamab +1 More

Onvansertib

Bevacizumab +3 More

View more colorectal-cancer clinical trials las-vegas

See more medical studies focusing on colorectal-cancer las-vegas

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top